Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies

NCT06298292 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Tyrosinemia, Type I
Tyrosinemia, Type II
Tyrosinemia, Type III
Alkaptonuria
Homocystine; Metabolic Disorder
MSUD (Maple Syrup Urine Disease)

Interventions

DIETARY_SUPPLEMENT: Zero minis (range of protein substitutes in tablet form)

Sponsor

metaX Institut fuer Diatetik GmbH

Collaborators

[object Object]
[object Object]